SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 8,907,000 | $17,329,459 | 1.40% |
| CSS LLC/IL | 7,106,000 | $13,798,218 | 0.91% |
| Aequim Alternative Investments LP | 5,000,000 | $9,672,055 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,948,000 | $11,571,045 | 0.23% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,051,000 | $3,989,195 | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,080,000 | $13,695,632 | 0.07% |
| Point72 Asset Management, L.P. | 9,007,000 | $17,447,371 | 0.05% |
| SSI INVESTMENT MANAGEMENT LLC | 257,000 | $496,500 | 0.04% |
| LORD, ABBETT & CO. LLC | 3,097,000 | $5,983 | 0.02% |
| D. E. Shaw & Co., Inc. | 4,100,000 | $7,953,192 | 0.01% |
| LOOMIS SAYLES & CO L P | 22,134 | $3,051 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| AMERICAN CENTURY COMPANIES INC | 75,000 | $145,081 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,000 | $3,888 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,000 | $5,796 | 0.00% |
| CITIGROUP INC | 152,000 | $293,650 | 0.00% |
| MORGAN STANLEY | 5,000 | $9,660 | 0.00% |
| FMR LLC | 2,990,000 | $5,776,414 | 0.00% |
| Invesco Ltd. | 250,000 | $482,978 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 18,000 | $34,932 | 0.00% |
This page lists SAREPTA THERAPEUTICS INC's shareholders in Q1 2023. To view SAREPTA THERAPEUTICS INC's shareholder history, click here.